Category: Hot-Topic-Sessions | Wednesday

Rethinking Treatment Limits: Can Older People Handle Glucose Sensing Technology?

Abbott |
Wednesday

Chair: Stephen Dixon (UK) 12:15 – 12:20 Welcome and introduction Stephen Dixon (UK) 12:20 – 12:40 Adoption and Efficacy of Glucose Sensing Technology in Older

Digital diabetes management: new perspectives for individualised care

Novo Nordisk A/S |
Wednesday

Chair: Richard Bergenstal (USA) 15:00 – 15:05 Welcome and introduction Richard Bergenstal (USA) 15:05 – 15:10 Clinical spotlight in T2D: how digital health can make

Connected Insulin Pens: Real World Experience

Eli Lilly and Company |
Wednesday

17:00 – 17:30 Connected Insulin Pens: Real World Experience Jens Kröger (GER)Eveleigh Nicholson (UK) 4 October 2023 17:00 – 17:30 CEST Spotlight Stage

Category: Hot-Topic-Sessions | Wednesday

Rethinking Treatment Limits: Can Older People Handle Glucose Sensing Technology? Abbott | Wednesday

Digital diabetes management: new perspectives for individualised care Novo Nordisk A/S | Wednesday

Connected Insulin Pens: Real World Experience Eli Lilly and Company | Wednesday

Rethinking Treatment Limits: Can Older People Handle Glucose Sensing Technology?

Abbott |
Wednesday

Digital diabetes management: new perspectives for individualised care

Novo Nordisk A/S |
Wednesday

Connected Insulin Pens: Real World Experience

Eli Lilly and Company |
Wednesday